Free Trial

ProVen VCT (LON:PVN) Trading Down 2.6% - What's Next?

ProVen VCT logo with Financial Services background
Image from MarketBeat Media, LLC.

Key Points

  • ProVen VCT shares fell 2.6% intraday to GBX 55.50, down from a prior close of GBX 57, and traded just 4 shares versus an average session volume of 443,644.
  • The stock is trading below its moving averages (50-day GBX 57.99, 200-day GBX 58.54) and has a market cap of £167.67 million, a P/E of 19.14 and a beta of 0.02.
  • ProVen VCT is a venture capital trust focusing on emerging growth-stage UK SMEs and AIM/unquoted companies (not startups) and also holds non-qualifying assets such as cash, liquidity funds and fixed-interest securities.
  • Five stocks we like better than ProVen VCT.

ProVen VCT (LON:PVN - Get Free Report)'s stock price fell 2.6% during mid-day trading on Wednesday . The company traded as low as GBX 55.50 and last traded at GBX 55.50. 4 shares were traded during mid-day trading, a decline of 100% from the average session volume of 443,644 shares. The stock had previously closed at GBX 57.

ProVen VCT Price Performance

The business's 50 day moving average price is GBX 57.99 and its 200-day moving average price is GBX 58.54. The company has a market cap of £167.67 million, a P/E ratio of 19.14 and a beta of 0.02.

ProVen VCT Company Profile

(Get Free Report)

ProVen VCT plc is a venture capital trust specializing in emerging growth stage investment,expansion and management buyouts. The fund invests in small and medium sized smaller companies. It does not invest in startups. It seeks to invest in non-qualifying investments including cash, liquidity funds, fixed interest securities, debt and debt related securities in growth companies and non-qualifying venture capital investments. It invests in unquoted and AIM-listed companies and SMEs based in United Kingdom.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in ProVen VCT Right Now?

Before you consider ProVen VCT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProVen VCT wasn't on the list.

While ProVen VCT currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines